Total investments 7
Average round size 
$21M
The average size of a deal this fund participated in
Portfolio companies 7
Rounds per year 1.40
Lead investments 2
Key employees Soon
Brookline, Massachusetts, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Myeloma Investment Fund:
Typical Co-investors
Myeloma Investment Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Myeloma Investment Fund:
There are no funds here. If we find new data, we will add it here.
Funds with similar focus
Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Al Mawarid | Beirut, Beyrouth, Lebanon |
| AVACO | Daegu, South Korea, Taegu-jikhalsi |
| Ayer Capital Management | California, San Francisco, United States |
| Belt Road Capital Management | Cambodia, Phnom Penh |
| Bios Partners | Fort Worth, Texas, United States |
| C-III Capital Partners | - |
| Chan Brothers Group | Central, Central Region, Singapore |
| Galois Capital | California, San Francisco, United States |
| High Peak Capital | - |
| Medical Technologies Innovation Asia | China, Hong Kong, Hong Kong Island |
| Motivate Venture Capital | Chicago, Illinois, United States |
| New Energy Solutions | China, Qingdao Shi, Shandong |
| Rare Ventures | New York, New York, United States |
| Synergia Capital Partners | Netherlands, Utrecht, Veenendaal |
| Team Launchpad | - |
| Tech Wildcatters | Dallas, Texas, United States |
| Venture Capital SpA | - |
| Zhejiang Silicon Paradise Asset Management Group | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nammi Therapeutics | $1M | 06 Aug 2024 | Los Angeles, California, United States | ||
Reverb Therapeutics | 15 Nov 2023 | Vancouver, British Columbia, Canada | |||
Triumvira Immunologics | $45M | 17 Mar 2022 | Austin, Texas, United States | ||
Indapta Therapeutics | $50M | 10 Feb 2022 | San Francisco, California, United States | ||
Fortis Therapeutics | $40M | 29 Mar 2021 | San Diego, California, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Myeloma Investment Fund?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 7
Average round size 21M
Rounds per year 1.40
Peak activity year 2022
Lead investments 2
Group Appearance index 0.57
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nammi Therapeutics | $1M | 06 Aug 2024 | Los Angeles, California, United States | ||
Reverb Therapeutics | 15 Nov 2023 | Vancouver, British Columbia, Canada | |||
Triumvira Immunologics | $45M | 17 Mar 2022 | Austin, Texas, United States | ||
Indapta Therapeutics | $50M | 10 Feb 2022 | San Francisco, California, United States | ||
Fortis Therapeutics | $40M | 29 Mar 2021 | San Diego, California, United States |
